Health care as a part of public protection systems in the European
Health policies, which are mainly the responsibility of the Member
States, seek primarily to allocate available resources in order to achieve the
best possible health outcomes. Health systems largely reflect health policies
and arise from the interplay of many complex factors: demographic (population
density and distribution, age structure, morbidity, mortality), ecological
(climate and environment), cultural (behaviour, education, training), economic
(industrial and occupational structure, level of development), social (public
and private protection schemes), medical (medical practice), technological
(availability of the most effective means) or legal (institutional practice).
They are thus social constructs and how they are organised depends on how
health services have developed and on the distinctive conditions in the various
countries. There are as many health systems as there are countries and there
have been many studies of the differences between them. We shall discuss them
in terms of funding, system structure, medical practice and health care
Funding reflects differences in the ability to mobilise resources
In macro-economic terms, the level of health expenditure per
capita reflects wealth of the country and the differences in the development of
Purchasing Power Parities (PPPs) are currency conversion rates
which express the purchasing powers of different currencies in terms of a
common unit. In other words, when a given sum of money is converted into
national currencies by means of PPPs, it will buy the same basket of goods and
services in all countries. PPPs are thus currency conversion rates which
eliminate the price differentials between countries.
The variation shown in table above is largely explained by the
relative wealth of the countries concerned. The OECD found that for every 100
dollars of difference in per capita
GDP there is a difference of 10.50 dollars in per capita health expenditure. A
10% difference in per capita GDP corresponds to a 14% gap in health
expenditure. Analysis of the data shows that differences in per capita GDP
explain 77% of the variance in health spending. The link between GDP and health
expenditure subsumes a complex set of relationships between different aspects
of social and cultural life, economic structures, demography and variables
specific to the health sector. The most striking feature of the last four
decades has been the rapid growth of health spending in all industrialised
countries, with the result that the proportion of gross domestic product (GDP)
devoted to health has virtually doubled.
The OECD established that the sharp rise in health expenditure in
the last few decades was mainly caused by the increase in prices and intensity
of use of medical services. The structure of health spending reveals a marked
concentration of the cost of health care on a fairly small segment of the
population. In some countries, 5% of the population have been found to account
for 50% of health expenditure. On average, those over 65 account
for four times as much as those of working age. If the health
expenditure of the high-risk groups were not borne by the wider community,
these persons would be unable to meet the cost of the treatment they require
and it is very likely that their health, which in any case is poor and at great
risk, would be further jeopardised.
Socialised funding of health expenditure applies the principle of solidarity.
This spreads the risks over the whole population, which generally contributes
to the financing of the system according to income, through taxation or social
security contributions. This is the only form of access to medical care which
is predominantly intergenerational. On average, public expenditure on health,
which mostly consists of spending on social protection, accounts for 70 to 85%
of total health expenditure in the EU. Paradoxically, it is the low-GDP
countries which have the lowest levels of socialised funding. The range extends
from 91.8% for Luxembourg to 57.7% for Greece.
Public expenditure as a percentage of total health expenditure
Private expenditure as a percentage of total health expenditure (1990-2002)
Two models and a wide range of variants of health care financing system
The current forms of social protection date from the beginning of the
industrial era. Industrial society is the context within which social
protection has developed. The initial model was that of the mutual benefit
societies of the 19th and the first half of the 20th century. In the course of
the 20th century, public protection developed on the basis of two models:
compulsory social insurance on the one hand and national health services on the
other. These were also known as the Bismarckian and Beveridgian systems after
their respective founding fathers.
The first public social protection system came into being in Germany.
Chancellor von Bismarck achieved his aim of defusing social tensions by
introducing a social insurance plan in 1880, organising protection against
social risks through insurance. His main innovation was to institutionalise the
principle of making insurance compulsory for both workers and employers and to
relate contributions to earned income. The first law instituting the principle
of compulsory social insurance was passed in Germany in 1881 and related to
sickness insurance. It was based on the practice applied at the time by
Germany's 10 000 sickness funds.
When the United Kingdom had to reorganise its hospital system
during the Second World War, it introduced a different philosophy of protection
against the risk of illness: the national health service. The National Health
Service model was devised by a task force chaired by Lord Beveridge and the
service was later set up in 1948 on the basis of four essential principles:
coverage of the whole population,
universal protection providing safeguards irrespective of the risk,
a unified system requiring centralised national administration, and
uniformity of benefits, matching response to need.
All European countries have based the structure and funding of their health
systems on one of these two approaches. Initially, the Bismarckian model spread
among the most highly industrialised countries in the first half of the 20th
century. Protection was initially limited to wage-earners and was gradually
extended to the whole population, except in Germany and the Netherlands, where
certain groups (mainly those earning above a certain income level) can or must
obtain private insurance.
In the Northern European countries, various reforms led to the establishment of
health systems in the 1960s. These were partly inspired by British experience
but at the same time rested on the principles of social insurance and local
management of the system. This combination is known as the Nordic model.
In the Mediterranean countries, the radical political changes of
the 1970s led to national health systems on the Beveridgian model, ensuring a
universal right to health care. It is always risky to construct typologies and
classify the various forms of social protection, which are the result of the
historical and institutional development of the country concerned. However, it
is generally accepted that the Member States of the European Union can be
grouped as follows:
Without going into the details of each system, this typology highlights the
guiding principles underlying the collectively funded systems for ensuring
access to health care.Social insurance systems generally offer category-based
In Belgium, there are two separate regimes: the first covering the whole
population apart from the self-employed and the second covering only the
self-employed and only for the major risks.
In France, there are three regimes: for employed workers and civil servants,
for the self-employed and for farmers.
In Germany, those with incomes above a certain level are not subject to
In the Netherlands, those with incomes above a certain level are excluded from
the public system. These systems are managed by the social partners.
In the countries with compulsory social insurance, two systems for
meeting medical costs may be Distinguished:
One group of countries, comprising Belgium, Luxembourg and France, reimburses
the cost of health care services. The insured person has a free choice of
health care provider, who may or may not be a party to the national agreement.
There is no tiered referral procedure for obtaining care.
A second group - Austria, Germany and the Netherlands - delivers benefits in
kind. In these countries, a patient insured under the compulsory health
insurance receives the care he needs without charge provided he uses a provider
approved by the scheme on the basis of an agreement between the scheme and the
service provider or his representatives. The social protection system ensures
that the patient receives the care his state of health requires. In these
countries, the general practitioner fulfills the role of gatekeeper: he refers
the patient to the specialist.
In the countries with national health services, delivery of health care and
ensuring its access are integrated into one single organisation. It is the
state, whether in centralised or decentralised mode, which satisfies citizens'
demand for care by ensuring access to health services. Generally, the patient
has no out of pocket payments to make except for any standard charges. Coverage
is usually universal. However, in some countries there are echoes of an earlier
category-based system. This is the case e.g. in Denmark (service provider
freely chosen by the patient) and in Ireland (free treatment or partial payment
depending on income). Most of these countries fund their systems from taxes
(United Kingdom, Ireland, Denmark, Finland, Sweden, Norway, Portugal).
Despite these fundamental differences, the position of certain countries within
the typology has changed considerably over the last twenty years under the
pressure of measures to contain health spending. Each model has thus
incorporated management and funding techniques based on the other. The health
care systems have thus tended to converge towards hybrid systems. The main
reason for these convergent trends is that the systems are facing the same
challenges. The first is the sharp rise in health expenditure resulting from
several factors such as rapid progress in developing new and costly medical
techniques, the high cost of new medicines placed on the market and the
medicalisation of social problems. Secondly, the slowdown in economic growth,
efforts to ensure sound public finances and the desire to reduce labour costs
in order to create employment are exerting greater pressure on collective
funding capacities. Finally, the demographic ageing of the populations is
weighing increasingly on collective provision for medical costs and especially
on the investment required to tackle the new needs to which this process gives
Wide discrepancies in medical practice
The diversity of the EU Member States' health care and care access
systems is apparent on many other levels: health outcomes, medical practice,
forms of health care consumption, etc. Two reliable indicators are life
expectancy at birth and the infant mortality rate. Their divergence, which is
sometimes considerable, reveals substantial differences from which some
citizens will benefit and others unfortunately suffer.
Among the EEA countries, the widest gap in life expectancy at
birth is 4.1 years for women (France/Denmark) and 5.5 years for men
(Iceland/Portugal). The 1995 infant mortality rate was 8.2 deaths per 1000 live
births in Greece, and only 4, less than half as high, in Finland.
The above map shows the rates per 100 000 head of population for
the main causes of death. The fact that the figures diverge - sometimes
considerably - within the EEA raises many questions as to the data collected,
the factors determining the onset of disease (quality of life, diet, working
conditions, environment, etc.) and the treatment provided, as well as
prevention. Cardiovascular diseases kill four times as many people in Portugal
as in France. Myocardial infarction causes four times as many deaths in Ireland
as in Luxembourg. Respiratory diseases lead to four times as many fatalities in
the United Kingdom as in Austria.
Another aspect of diversity in the health sector, both between countries and
within each country, is the persistence of social inequalities. These are
apparent as inequalities in consumption and treatment. French research is very
revealing. It shows, for example, that the death rates for men aged 25 to 64
and employed as blue or white-collar workers were three times as high as those
for the higher professions (for the period 1989-1994). Ten years before, this
excess mortality factor was 2.5. In other terms, it is the social categories
with the lowest death rates which benefit most from the general increase in
life expectancy. In France, the life expectancy of male manual workers at the
age of 35 is 8.8 years less than that of primary school teachers and 7.3 years
less than that of senior managers and practitioners of the liberal professions.
Mortality rates differ from birth and are probably linked with the state of
health of the parents and with circumstances and social conditions during
pregnancy. Analysis of the causes of death reveals mortality differentials
depending on social class in both France and the United Kingdom. These are
particularly marked for deaths due to tuberculosis, cirrhosis, lung disease,
accidents and certain cancers.
Recent French statistics illustrate mortality differences between
social classes for most diseases (premature death rate from alcoholism and
cancers of the upper aerodigestive tract ten times as high for
white/blue-collar workers as for managers and the liberal professions, four
times as high for lung cancer, three times for cerebrovascular and hypertensive
diseases, traffic accidents, suicide). DESPLANQUES G. ibid. demonstrated the
link between mortality and level of education. Male mortality is inversely
proportional to the educational level. He also observes that death rates are
higher for the unemployed in all social categories and as one descends the
social scale this excess mortality increases.
Health care consumption profiles differ according to social category. The
less-advantaged tend to consult general practitioners and to be treated more in
hospital. The more affluent consume more specialist consultations, dental care,
medicines, whether prescribed or otherwise, blood tests, physiotherapy and home
nursing. For managers and white-collar workers, differences in the frequency of
consultation of doctors and dentists increased during recent decades.
Social inequalities in health outcomes are explained firstly by disparities in
social conditions and the related cultural and behavioural differences. Another
explanatory factor is access to treatment. The most disadvantaged households
tend to postpone or renounce to certain types of care because health spending
represents a relatively high proportion of their budget. This leads to the
development of serious illnesses. The poorest strata of the population end up
more often in hospital and spend more time there than the better-off.
Various studies have identified behaviour patterns which endanger health. These
are more common among the less well-off. Three examples are smoking, diet and
physical activity. The percentage of smokers is higher among the lower classes.
However, the link between smoking and class varies greatly from country to
country. It is very strong in France, Italy and Norway and very weak in the
United Kingdom. In Spain, the well-off tend to smoke more. The same applies to
alcohol consumption. The disadvantaged tend to have a less well-balanced diet.
Fat consumption has been found to be twice as high. Poor diet increases the
risks of diabetes, obesity and anaemia and reduces resistance to disease.
Finally, managers average twice as much sporting activity as manual workers.
Inter-country and intra-country comparisons reveal considerable variation in
the frequency of a particular medical operation or the consumption of medicines
or treatments for the same illness. The number of pacemakers fitted per million
head of population16 is 600 in Belgium, 450 in France and the former West
Germany, 300 in Denmark and a little over 200 in the United Kingdom. The index
for ambulatory pharmaceuticals consumption per head of population is 180 in
France, 140 in Italy, 100 in Belgium, 40 in the Netherlands and under 35 in
The number of patients treated for kidney failure is 400 per million in
Belgium, 300 in Italy and France and 250 in Greece. In Belgium, the number of
days spent in psychiatric hospitals per 1000 inhabitants varies greatly from
region to region: 346 days in Brussels, 587 in Wallonia and 861 in Flanders. A
recent study on hysterectomy provided further confirmation of the many
observations of uneven health practice, with large variations from country to
country and from region to region within Belgium.
The risk of undergoing the operation is an inverse function of the patient's
educational level and income. There are substantial variations in the technique
employed (abdominal or vaginal surgery with or without laparoscopy). The main
explanatory factors are the training and opinion of the surgeon and the age of
the patient. Cost and length of stay depend on the hospital concerned. The
indicators of health outcomes and consumption of health care reveal large
differences between the countries. While some part is played by
population-related factors (demographic composition, differential morbidity,
differences in unhealthy lifestyles), little is yet known about their
importance. Other factors which operate additionally or in conjunction relate
to the supply of health care (organisation, funding, prescribers' attitudes)
and more general factors which may be cultural (attitude to health, illness
etc.), economic and political (organisation of social protection).
Cost containment and related reforms
The diversity of social protection systems has spawned a host of
cost containment mechanisms. In many countries, policy-makers have concentrated
on controlling supply, using a wide range of complex and ingenious measures,
which fall into four categories:
direct short-term controls (budget capping, staff cuts and wage restrictions,
price and quantity controls);
indirect short-term controls (medical profiles, changes in remuneration
miscellaneous incentives and controls (hospital and medical equipment planning,
encouragement of alternatives to in-patient treatment, gatekeeping);
direct long-term action to limit numbers of practitioners (numerus clausus or
course admission quotas).
Generally speaking, states which are forced to stabilise the level of health
expenditure in order to curb public funding of health care seek to impose
overall and sectoral budgets and regulate growth of public spending. Such
measures tend to shift more of the burden of health care funding on to
households by reducing cover or failing to keep pace with rising costs. Today,
budgeting and cost sharing by patients apply in virtually all systems. Higher
patient contributions are intended to discourage or limit demand. However, to
reduce the negative impact of such policies on access to treatment and to make
them more acceptable, certain categories, such as low-income groups and/or
patients suffering from serious or chronic illnesses, are entirely or partly
exempted. Cost containment is part of the efforts to achieve a more rational
allocation of resources according to needs. Since the mid-1980s, ambitious
reform projects have sought to attain this rationality/efficiency by
introducing competition among the actors in the health care sector.
As patients and/or insureds are given "consumer's freedom of choice", providers
and/or insurers (purchasers of care), being alloted a prospective budget are
incited to adopt an accountable approach in providing quality care at minimum
cost. Even if this approach does not seem to have much effect in curtailing
expenditure, the reforms which it drives are changing the health care
landscape, leading to mergers and reinforcing the trend towards
regionalisation. The quest for rationalisation is also apparent in the concept
of "evidence based medicine", i.e. reimbursement of the cost of treating an
illness is determined on the basis of the diagnostic and therapeutic methods
whose effectiveness has been demonstrated.
A benchmark is thus established on the basis of the current state of knowledge
and the treatment given is compared with this benchmark. However, these methods
of defining "quality standards" cannot be applied to all medical practice. In
particular, they are inappropriate for palliative care. Since the cost control
measures strike against an incompressible mass of highly concentrated costs,
they yield only modest savings and the risk of care rationing is therefore
increased. Specific examples are the development of waiting lists or refusal to
provide particular kinds of treatment to patients above a certain age. Overall,
the reforms pursued over the last twenty years have concentrated primarily on
restricting supply and less on adjusting demand. In a second phase, they have
extended to the areas of responsibility of the parties concerned.